Cite
HARVARD Citation
Angelis, V. et al. (n.d.). First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experience. Lung cancer. pp. S41-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Angelis, V. et al. (n.d.). First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experience. Lung cancer. pp. S41-. [Online].